Why can't atrial fibrillation (afib) be converted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 23, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Atrial fibrillation (AFib) cannot always be converted to normal sinus rhythm due to several factors, including the duration of AFib, underlying structural heart disease, left atrial enlargement, and the presence of comorbidities like hypertension or sleep apnea. The primary reasons for failed conversion of AFib to normal sinus rhythm include:

  • Duration of AFib: Chronic AFib is more difficult to convert than recent-onset AFib
  • Underlying structural heart disease
  • Left atrial enlargement
  • Presence of comorbidities like hypertension or sleep apnea For patients with AFib lasting more than 48 hours, conversion attempts require anticoagulation for at least 3-4 weeks before cardioversion to prevent stroke, as recommended by the ACC/AHA/ESC 2006 guidelines 1. Medications used for chemical cardioversion include:
  • Amiodarone (typically 200-400 mg daily)
  • Flecainide (50-200 mg twice daily)
  • Propafenone (150-300 mg three times daily)
  • Dofetilide (125-500 mcg twice daily based on kidney function) Electrical cardioversion may be attempted when medications fail, with a success rate exceeding 90% with the use of external biphasic defibrillators 1. Some patients develop permanent AFib where the risks of conversion outweigh benefits, particularly in elderly patients with multiple comorbidities. In these cases, rate control with beta-blockers (metoprolol, carvedilol), calcium channel blockers (diltiazem, verapamil), or digoxin, along with anticoagulation therapy, becomes the primary management strategy rather than attempting rhythm control. It is essential to consider patient preference when making the choice between electrical and pharmacologic conversion, as well as to assess the risk of thromboembolic events, which does not seem to differ between electrical and pharmacologic conversion 1. The use of antiarrhythmic therapy before electrical cardioversion does not improve the efficacy of acute conversion, although it may be used when maintenance therapy will be used after cardioversion 1. Overall, the management of AFib requires a comprehensive approach, taking into account the individual patient's characteristics, medical history, and preferences.

From the Research

Reasons for Failure to Convert Atrial Fibrillation

  • Atrial fibrillation (AF) may not be convertible to sinus rhythm due to various factors, including the duration of AF, underlying cardiac disease, and the presence of comorbidities 2, 3.
  • The success of conversion to sinus rhythm depends on the method used, with electrical cardioversion having a higher success rate compared to pharmacological cardioversion in the short-term 2.
  • Pharmacological cardioversion may be less effective in patients with chronic AF or those with underlying structural heart disease 4, 5.

Factors Influencing Conversion

  • The duration of AF is a significant factor in determining the success of conversion, with recent-onset AF being more likely to be converted to sinus rhythm 4, 6.
  • The type of antiarrhythmic drug used can also influence the success of conversion, with different drugs having varying efficacy and safety profiles 4, 6.
  • The presence of underlying cardiac disease, such as heart failure or valvular disease, can also impact the success of conversion 3, 5.

Clinical Considerations

  • The decision to convert AF to sinus rhythm should be based on individual patient factors, including symptoms, underlying cardiac disease, and the presence of comorbidities 2, 5.
  • The potential risks and benefits of conversion, including the risk of proarrhythmic drug effects, should be carefully considered 5.
  • The use of anticoagulation therapy is crucial in patients with AF, particularly those at high risk of stroke, to reduce the risk of embolic events 2, 3.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the next step for managing atrial fibrillation (Afib) that won't convert to normal sinus rhythm (NSR) on intravenous (IV) Cardizem (diltiazem)?
What is the approach to managing atrial fibrillation?
What are the management options for atrial tachycardia?
What is the recommended approach for analgesia and energy levels for cardioversion in patients with fibrillation?
What oral medication is recommended to maintain sinus rhythm in a patient with a history of paroxysmal atrial fibrillation (A-fib) with rapid ventricular response (RVR) who has converted to sinus rhythm?
What is the diagnosis for a patient presenting with a cough, lower lung congestion, and yellow sputum, with an onset of symptoms 6 days ago, accompanied by fever, and previously treated with over-the-counter (OTC) sinus medications and Tamiflu (oseltamivir) after exposure to influenza (flu)?
Does tramadol contain acetaminophen (paracetamol)?
What is the cause of postprandial (after eating) dizziness in a pregnant woman with normal glucose levels and routine laboratory results?
What is the treatment for pediatric pneumonia?
Does pulmonary embolism (PE) elevate procalcitonin levels?
What is the diagnosis for a 17-year-old patient with sharp left forearm wrist pain, exacerbated by movement and activity, particularly after a boxing match, with a pain scale of 9/10, and worsened by morning activities due to increased movement during sleep?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question